INTRODUCTION
============

Mesenchymal stem cells (MSCs) are multipotent adult stem cells that can differentiate into multiple cell types ([@b3-bt-23-517]) such as neurons, hepatocytes, cardiomyocytes, and epithelial cells. Transplantation of MSCs has been used in the treatment of certain tissue injuries such as ischemic heart failure and hind-limb ischemia ([@b24-bt-23-517]). However, survival of the incorporated MSCs is reduced by the hostile microenvironment of ischemic tissue (characterized by hypoxia and free radical damage), thus inhibiting vasculogenesis and tissue repair. This, therefore, presents a significant MSC-based therapeutic challenge.

Researchers are attempting to enhance stem cell survival and function to overcome this problem; however, solutions re main limited. Recent evidence has suggested that ROS play a major role in the pathogenesis of hypertension and atherosclerosis in animals and humans ([@b9-bt-23-517]; [@b11-bt-23-517]; [@b28-bt-23-517]). A high level of ROS causes endothelial dysfunction and impairs vasodilation, thus contributing to the development of cardiovascular disease. In patients with heart failure who were treated by MSC transplantation, high levels of reactive oxygen species (ROS) are associated with significantly lower MSC counts than those observed in patients treated with an antioxidant. MSCs exposed to prolonged oxidative stress may be functionally impaired ([@b18-bt-23-517]). Survival of MSCs after intramyocardial transplantation can be a strong indicator of a favorable cardiovascular prognosis in cell-based therapy ([@b2-bt-23-517]). These studies suggest that the ischemic microenvironment, including the adverse oxidative stress response, has a deleterious effect on MSC survival and function. Therefore, protection of MSCs from ischemia-induced apoptosis may prove beneficial for cell therapy.

Lycopene, a naturally occurring carotenoid found in tomatoes and tomato-plant extracts, exhibits potent free radical-scavenging activity ([@b20-bt-23-517]). Lycopene modulates redox-sensitive molecular pathways by inhibiting the production of ROS ([@b27-bt-23-517]; [@b4-bt-23-517]). Cell culture studies have shown that lycopene protects endothelial cells (ECs) against oxidative injury ([@b26-bt-23-517]). Although many studies have shown the beneficial effects of lycopene, the protective effect of lycopene on oxidative stress and the mechanism underlying anti-oxidant property of lycopene in a variety of stem/progenitor cells have not been well studied. In this study, we assessed the protective effect of lycopene on ischemic conditions in MSCs and elucidated the anti-oxidant mechanism of lycopene against oxidative stress.

MATERIALS AND METHODS
=====================

Materials
---------

Human MSCs (hMSCs) were obtained from American Type Culture Collection (Manassas, VA, USA). Fetal bovine serum (FBS) was purchased from Biowhittaker (Walkersville, MD, USA). Hydrogen peroxide solution was obtained from the Sigma Chemical Company (St. Louis, MO, USA). Phospho-p38 mitogen-activated protein kinase (MAPK), p38 MAPK, phospho-c-Jun N-terminal kinase (JNK), JNK, phospho-ataxia telangiectasia mutated (ATM), ATM, phospho-p53, p53, phospho-PI3K, PI3K, phospho-Akt, and Akt antibodies were obtained from New England BioLabs (Hertfordshire, UK). Manganese superoxide dismutase (MnSOD), Bcl-2, BAX, cleaved caspase-3 (c-caspase-3), and poly (ADP ribose) polymerase-1 (PARP-1) were purchased from Santa Cruz Biotechnology (Delaware, CA, USA). Goat anti-rabbit or mouse IgG antibody was purchased from Jackson ImmunoResearch (West Grove, PA, USA). Lycopene and Akt inhibitor were purchased from Sigma (St. Louis, MO, USA).

Human MSC cultures
------------------

Human adipose tissue-derived MSCs were obtained from the American Type Culture Collection (Manassas, VA, USA). MSCs were cultured in low-glucose Dulbecco's Modified Eagle's Medium (DMEM) supplemented with 10% fetal bovine serum and 100 U / ml of penicillin/streptomycin. The cells were placed in a 5% CO~2~ incubator with saturated humidity at 37°C.

Chemicals treatment of MSCs
---------------------------

MSCs were washed twice with PBS, and the medium was exchanged with fresh minimum essential medium (MEM)-alpha supplemented with 10% FBS. To investigate the apoptosis signaling pathway, MSCs were pretreated with lycopene (10 μg/ml) at 37°C for 30 min, and then treated with H~2~O~2~ (200 μM) for the indicated time periods (0, 1, 2, 3, and 4 h). To assess various cell signaling pathways, MSCs were treated with lycopene along for time periods (0, 15, 30, 60, and 120min or 0, 24, and 48 h). Treatment with an Akt inhibitor (10−6 M) was carried out before lycopene treatment, at 37°C for 30 min.

Intracellular reactive oxygen species (ROS) assay
-------------------------------------------------

CM-H~2~DCFDA (DCF-DA), which acts as an H~2~O~2~-sensitive fluorophore, was used to detect the H~2~O~2~-induced production of ROS. DCF-DA (10 μM) was added to the cells and incubated for 30 min at room temperature in the dark. The cells were then viewed with a laser confocal microscope (600×; Fluoview 1000, Olympus, Tokyo, Japan) with excitation and emission wavelengths of 488 nm and 515--540 nm, respectively.

Cell viability assay
--------------------

At subconfluency, exponentially growing MSCs were incubated in a 96-well plate with lycopene for various durations. Cell viability were determined using a modified 3-(4,5-dimethyl-thiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, which is based on the conversion of the tetrazolium salt 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2-tetrazolium to formazan by mitochondrial NAD(P)H-dependent oxidoreductase enzymes. Formazan levels were quantified by measuring the absorbance at 575 nm using a microplate reader (Tecan, Männedorf, Switzerland).

TUNEL assay
-----------

TdT-mediated dUTP Nick End Labeling (TUNEL) assay was performed using TdT Fluorescein In Situ Apoptosis Detection Kit (Trevigen Inc, Gaithersburg, MD, USA). The MSCs were pre-treated lycopene (30 min) and after treated H~2~O~2~ (4 h). Then, MSCs were labelled in according to manufacturer's instructions. Stained MSCs were visualized with fluorescent microscope (ZEISS, Oberkochen, Germany).

Western blot analysis
---------------------

Cell homogenates (20 μg protein) were separated via 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), and the proteins were transferred to a nitrocellulose membrane for antibody probing. After the blots had been washed with TBST (10 mM Tris-HCl (pH 7.6), 150 mM NaCl, 0.05% Tween-20), the membranes were blocked with 5% skim milk for 1 h and incubated with the appropriate primary antibodies at the dilutions recommended by the supplier. The membranes were then washed, and the primary antibodies were detected using goat anti-rabbit IgG or goat anti-mouse IgG conjugated to horseradish peroxidase. The bands were visualized by enhanced chemiluminescence (Amersham Pharmacia Biotech, England, UK).

Statistical analysis
--------------------

The results are presented as means ± standard error. All experiments were analyzed by analysis of variance (ANOVA), followed by a comparison of the treatment and control groups using the Bonferroni-Dunn test. A *p*-value of \<0.05 was considered statistically significant.

RESULTS
=======

The protective effect of lycopene on H~2~O~2~-induced apoptosis
---------------------------------------------------------------

To investigate the protective effect of lycopene against oxidative stress-induced cell death, MSCs were treated with H~2~O~2~ (200 μM) for the indicated periods (0, 1, 2, 3, and 4 h). The maximal effect of H~2~O~2~-induced cell death in MSC was observed after 4 h of treatment ([Fig. 1A](#f1-bt-23-517){ref-type="fig"}), and pre-treatment with lycopene increased the viability of MSC at concentration ≥10 μg/mL ([Fig. 1B](#f1-bt-23-517){ref-type="fig"}).

Lycopene-mediated inhibition of H~2~O~2~-induced ROS generation and phosphorylation of MAPK and ATM
---------------------------------------------------------------------------------------------------

To determine the degree of involvement of ROS in H~2~O~2~-induced apoptosis, DCF-DA was used as an indicator of ROS production, and changes in the intracellular peroxide levels were measured. As shown in [Fig. 2A](#f2-bt-23-517){ref-type="fig"}, when MSCs were exposed to 200 μM H~2~O~2~ for 1 h, intracellular ROS levels were significantly increased compared to those in untreated cells, indicating that H~2~O~2~ enhances ROS production. However, treatment with lycopene (10 μM) significantly attenuated the observed increase in ROS levels. To assess the involvement of MAPKs in H~2~O~2~-induced cell injury, cells were treated with H~2~O~2~ for different periods (0--120 min). H~2~O~2~ increased JNK and p38 MAPK phosphorylation ([Fig. 2B](#f2-bt-23-517){ref-type="fig"}), and activation of these MAPKs was inhibited by lycopene treatment ([Fig. 2C](#f2-bt-23-517){ref-type="fig"}). Next, the involvement of ATM and p53 activation in H~2~O~2~-induced cell injury was evaluated. H~2~O~2~ increased ATM and p53 phosphorylation in a time-dependent manner ([Fig. 3A, 3B](#f3-bt-23-517){ref-type="fig"}). However, ATM and p53 activation was also inhibited by lycopene treatment ([Fig. 3C, 3D](#f3-bt-23-517){ref-type="fig"}). These results indicated that lycopene decreased oxidative stress-induced ROS levels and inhibited the phosphorylation of apoptosis-induced cell signaling pathways.

Lycopene pretreatment affects H~2~O~2~-induced expression of apoptotic proteins in MSCs
---------------------------------------------------------------------------------------

To investigate the effect of lycopene on regulation of apoptosis-associated protein in ischemic condition, MSCs were treated with H~2~O~2~ for 0--4 h, and the expression of Bcl-2 (anti-apoptotic protein) and Bax (pro-apoptotic protein was evaluated by western blot analysis. H~2~O~2~ increased Bax protein levels and decreased Bcl-2 expression in MSCs in a time dependent manner, compared with that observed in the control ([Fig. 4A](#f4-bt-23-517){ref-type="fig"}). However, pretreatment with lycopene significantly increased Bcl-2 expression and decreased Bax expression ([Fig. 4B](#f4-bt-23-517){ref-type="fig"}). To further examine the signaling pathways involved in the protective effect of lycopene against H~2~O~2~-induced apoptosis in MSCs, the expression of the pro-apoptotic regulators, cleaved caspase-3 (C-Caspase-3) and PARP-1 (C-PARP-1), was assessed by western blot analysis. H~2~O~2~ treatment resulted in the up-regulation of C-Caspase-3 and C-PARP-1 ([Fig. 4C](#f4-bt-23-517){ref-type="fig"}), but pretreatment with lycopene significantly decreased their expressions ([Fig. 4D](#f4-bt-23-517){ref-type="fig"}). In addition, TUNEL assay indicated that pretreatment with lycopene significantly attenuated H~2~O~2~-induced apoptosis in MSCs, compared with other group ([Fig. 4E](#f4-bt-23-517){ref-type="fig"}). These findings suggested that the anti-apoptotic effects of lycopene were involved in the regulation of apoptosis-associated protein expressions.

Akt regulates MnSOD expression in lycopene-stimulated MSCs under oxidative stress conditions
--------------------------------------------------------------------------------------------

To elucidate the mechanism involved in the protective effects of lycopene, we tested the hypothesis that lycopene induced the attenuation of ROS generation by activating Akt signaling pathways. Using western blot analysis, we assessed the phosphorylation of PI3K and Akt in MSCs treated with lycopene for various periods (0--120 min). The results showed that phosphorylation of PI3K and Akt was increased in lycopene-treated MSCs within 15 min post treatment, and this activation was sustained for 120 min ([Fig. 5A](#f5-bt-23-517){ref-type="fig"}). MnSOD is an antioxidant protein that eliminates superoxides. To investigate whether the antioxidant effects of lycopene are associated with the Akt and MnSOD signaling pathways in MSCs, the cellular expression level of MnSOD in response to lycopene was assessed by western blot analysis. Lycopene increased MnSOD expression at 24 h post treatment ([Fig. 5B](#f5-bt-23-517){ref-type="fig"}), and this increase in MnSOD expression was suppressed by Akt inhibition ([Fig. 5C](#f5-bt-23-517){ref-type="fig"}). Moreover, lycopene-induced reduction in ROS levels was also abrogated by Akt inhibition ([Fig. 5D](#f5-bt-23-517){ref-type="fig"}), indicating that Akt activation plays a key role in the anti-oxidant effect of lycopene in MSCs via the expression of MnSOD.

DISCUSSION
==========

Previous studies demonstrated that transplantation of stem/ progenitor cells such as MSCs, bone marrow stem cells, and cardiac stem cells reduces ischemia-induced myocardial tissue injury and improves left ventricular function ([@b14-bt-23-517]; [@b19-bt-23-517]; [@b30-bt-23-517]). However, stem cells transplanted into the ischemic myocardium are susceptible to an adverse tissue microenvironment that has reduced oxygen supply and free radical damage. Exposure to these adverse conditions compromises the full therapeutic benefits of transplanted MSCs. Thus, protection of MSCs from cell death in the ischemic microenvironment is crucial for the successful advancement of such stem cell-based therapies in the clinical setting. Lycopene is a carotenoid that belongs to a series of pigments ([@b15-bt-23-517]). Carotenoids are naturally occurring products that are widespread in vegetables and fruits ([@b29-bt-23-517]; [@b10-bt-23-517]). Lycopene is reported to be one of the most potent antioxidants among the carotenoids ([@b21-bt-23-517]). Furthermore, lycopene can restore free radical-induced reactions such as the production of ROS or other peroxy radicals ([@b8-bt-23-517]; [@b21-bt-23-517]). However, these beneficial effects of lycopene in stem/progenitor cells have not been well reported. Therefore, in the present study, we evaluated the ability of lycopene to protect MSCs from ischemia-induced apoptosis. We found that lycopene restored the viability of MSCs, which was adversely affected by H~2~O~2~, in a dose-dependent manner. Moreover, lycopene blocked the generation of ROS in H~2~O~2~-treated MSCs, suggesting that lycopene might exert anti-apoptotic activities via inhibition of ROS generation.

Addition of extracellular H~2~O~2~ increased the intracellular levels of ROS, which subsequently activated p38MAPK and JNK. These signaling kinases transduce extracellular stress stimuli into cellular responses via phosphorelay cascades. These MAPK components function in a pleiotropic manner to regulate a broad variety of physiological functions such as cell growth, differentiation, and apoptosis ([@b16-bt-23-517]; [@b12-bt-23-517]). ATM is one of the key regulatory molecules in oxidative stress-induced apoptosis ([@b6-bt-23-517]). The H~2~O~2~-mediated increase in ROS production results in ATM phosphorylation, which, in turn, activates p53. In ischemic condition, we observed that lycopene treatment inhibited H~2~O~2~-induced activation of these signaling molecules, suggesting that lycopene protected MSCs against ROS damages through the regulation of extracellular stress-associated signal pathway.

Apoptosis plays a significant role in the pathophysiology of cardiovascular injury ([@b25-bt-23-517]; [@b13-bt-23-517]) and occurs via a cascade of cellular events involving several apoptosis-regulatory genes. The Bcl-2 family of proteins represents a critical checkpoint in major apoptotic signal transduction cascades by acting upstream of irreversible damage to cellular constituents ([@b32-bt-23-517]) ([@b33-bt-23-517]). The Bcl-2/Bax ratio is a determining factor in the regulation of apoptotic cell death ([@b1-bt-23-517]). Caspase-3, one of the key executors of apoptosis ([@b7-bt-23-517]), is essential for DNA fragmentation and the morphological changes associated with apoptosis ([@b17-bt-23-517]). Caspase-3 is activated during apoptosis and is responsible for the processing of cellular proteins, including the cleavage of PARP to generate 85- and 31-kDa fragments ([@b5-bt-23-517]). PARP cleavage is therefore a hallmark of apoptosis ([@b23-bt-23-517]). In the present study, H~2~O~2~ treatment resulted in decreased expression of the Bcl-2/Bax ratio at the protein level, activation of caspase-3, and cleavage of PARP-1 in MSCs. Pretreatment with lycopene restored the Bcl-2/BAX ratio and inhibited caspase-3 activation and PARP cleavage. Taken together, our results suggest that inhibition of apoptosis may be a key mechanism underlying the cyto-protective effect of lycopene.

Although several studies have reported the beneficial effects of lycopene in various biological processes, lycopene's mechanism of action has not been fully elucidated. Lycopene treatment enhanced heme oxygenase-1 (HO-1) gene expression via activation of the PI3K/Akt pathway ([@b31-bt-23-517]). The present study demonstrated a new mechanism of action for lycopene against oxidative stress. Our findings show that its pro-survival effect in MSCs is mediated by activation of Akt signaling. In addition, lycopene treatment enhanced the survival of MSCs in ischemic condition via the increase in Akt-associated MnSOD expression. These results are in agreement with those of a previous report, which demonstrated that Akt pathway engagement prevents increases in intracellular ROS levels, activation of the pro-apoptotic molecule JNK, and consequently apoptosis ([@b22-bt-23-517]). These findings suggest that lycopene reduced the cellular ROS levels of MSCs in ischemic condition via the Akt-MnSOD secretion circuit.

[Fig. 6](#f6-bt-23-517){ref-type="fig"} summarizes the multiple effects of lycopene on oxidative stress in MSCs. In oxidative stress condition, lycopene inhibits extracellular stress signal pathway, such as p38 MAPK, JNK, ATM, and p53, and regulates the expression of anti- and pro-apoptosis associated proteins. Moreover, to eliminate oxidative stress-induced cellular ROS, lycopene increases in the level of MnSOD via PI3K-Akt phosphorylation cascade, resulting in augmentation of MSCs survival against ischemic injury.

In conclusion, the present study demonstrates that lycopene can protect MSCs from ischemia-induced apoptosis by inhibiting ROS generation, possibly via the Akt/MnSOD pathway, indicating that lycopene may reduce the spread of ischemic injury and rescue dying MSCs in the ischemic region. Lycopene can, therefore, be developed as a cyto-protective agent in ischemic diseases.
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![Effect of lycopene on H~2~O~2~-induced apoptotic cell death in MSCs. (A) MSCs were treated with H~2~O~2~ (200 μM) for 0--4 h, and cell viability was assessed. Values are expressed as the mean ± SD. ^\*\*^*p*\<0.01 vs. control. (B) After lycopene pretreatment (0--20 μM) for 30 min, cell viability was assessed followed by 4 h of exposure to H~2~O~2~. Values are expressed as the mean ± SD. ^\*\*^*p*\<0.01 vs. control, \#*p*\<0.05 and ^\#\#^*p*\<0.01 vs. H~2~O~2~ alone.](bt-23-517f1){#f1-bt-23-517}

![Lycopene inhibits intracellular ROS generation and activation of p38 MAPK and JNK. (A) MSCs were treated with lycopene for 30 min prior to H~2~O~2~ (200 μM) treatment, and cellular ROS levels were measured using the ROS-sensitive fluorophore CM-H~2~DCFDA (DCF-DA) by confocal microscopy. The image is representative of four independent experiments. (B) MSCs were treated with H~2~O~2~ (200 μM) for 0--120 min, and the levels of phosphorylated p38 MAPK and JNK were detected by western blot analysis. (C) MSCs were treated with lycopene (10 μM), followed by H~2~O~2~, and the levels of phosphorylated p38 MAPK and JNK were detected by western blot analysis.](bt-23-517f2){#f2-bt-23-517}

![Lycopene inhibits the ATM and p53 pathways. (A--B) MSCs were treated with H~2~O~2~ (200 μM) for 0--120 min, and the levels of phosphorylated ATM and p53 were detected by western blot analysis. (C--D) MSCs were treated with lycopene (10 μM), followed by H~2~O~2~, and the levels of phosphorylated ATM and p53 were detected by western blot analysis.](bt-23-517f3){#f3-bt-23-517}

![Effect of lycopene on H~2~O~2~-induced regulation of Bcl-2, Bax, and cleaved PARP-1 and caspase-3. (A) MSCs were treated with H~2~O~2~ for 0--4 h, and then the expression levels of Bcl-2 and Bax were assessed by western blot analysis. (B) MSCs were treated with lycopene (10 μM), followed by H~2~O~2~, and the levels of Bcl-2 and Bax were detected by western blot analysis. (C) MSCs were treated with H~2~O~2~ for 0--4 h, and the amounts of the cleaved caspase-3 and PARP-1 were assessed by western blot analysis. (D) MSCs were treated with lycopene (10 μM), followed by H~2~O~2~, and the amounts of cleaved caspase-3 and PARP-1 were detected by western blot. (E) MSCs were treated with lycopene for 30 min prior to H~2~O~2~ (200 μM) for 4 h treatment, and DNA damage was analyzed using TUNEL assay. Representative images of TUNEL positive cells (green) show H~2~O~2~-induced apoptotic MSCs.](bt-23-517f4){#f4-bt-23-517}

![Effect of lycopene-mediated induction of the Akt pathway on MnSOD expression. (A) MSCs were treated with lycopene (10 μM) for 0--120 min. The levels of phosphorylated PI3K and Akt were detected by western blot analysis. (B) MSCs were treated with lycopene for 0--48 h. Total cell lysates were subjected to SDS-PAGE and probed with an anti-MnSOD antibody. (C) MSCs were treated with an Akt inhibitor prior to lycopene treatment (48 h), after which the expression of MnSOD was detected. (D) MSCs were treated with lycopene and/or an Akt inhibitor prior to H~2~O~2~ treatment, and then DCF-DA was assessed by confocal microscopy.](bt-23-517f5){#f5-bt-23-517}

![Schematic representation of proposed mechanisms by which lycopene prevents oxidative stress in MSCs. Oxidative stress triggers the induction of reactive oxygen species (ROS) in MSCs. ROS lead to the phosphorylation of ATM and apoptosis-associated MAPK (p38 and JNK) signaling pathway, resulting in augmentation of the phosphorylation of p53. Moreover, ROS break the balance between Bax and Bcl2, resulting in the induction of apoptosis via the cleavage of PARP-1 and Caspase-3. Lycopene suppresses oxidative stress-induced apoptosis through Akt-MnSOD axis. In addition, lycopene decreases the phosphorylation of apoptosis-associated MAPK (p38 and JNK). These effects of lycopene on oxidative stress induce the decrease in the phosphorylation of ATM-p53 signaling pathway and the protection of cleavage PARP-1 and caspase-3, resulting in prevention of apoptosis and augmentation of survival in MSCs. ATM; ataxia telangiectasia mutated serine/threonine protein kinase, MAPK; mitogen-activated protein kinases, PARP-1; poly \[ADP-ribose\] polymerase 1, PI3K; phosphatidylinositol-4,5-bisphosphate 3-kinase.](bt-23-517f6){#f6-bt-23-517}
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